Skip to main content

Table 1 Comparison of characteristics between ST17 and non-ST17 cohorts

From: Sequence type 17 is a predictor of subsequent bacteremia in vancomycin-resistant Enterococcus faecium-colonized patients: a retrospective cohort study

Variables

Total

(n = 221)

Cohort

ST17

(n = 52)

non-ST17

(n = 169)

P value

Virulence factors

    

 esp+hyl+

179 (80.9)

51 (98.1)

128 (75.7)

 < 0.001

Age/sex/BMI

    

 Age (mean ± SD)

62.3 ± 14.5

64.7 ± 14.5

61.5 ± 15.0

0.752

 Male

132 (59.7)

28 (53.8)

104 (61.5)

0.323

 BMI ≥ 25 kg/m2

48 (21.7)

10 (19.2)

38 (22.5)

0.619

Underlying condition

 Decompensated LC

36 (16.3)

6 (11.5)

30 (17.8)

0.289

 AKI requiring RRT

58 (26.2)

10 (19.2)

48 (28.4)

0.189

 Diabetes mellitus

57 (25.8)

45 (26.6)

12 (23.1)

0.609

 Cancer

67 (30.3)

18 (34.6)

49 (29.0)

0.441

 Hematologic malignancy

44 (19.9)

6 (11.5)

38 (22.5)

0.084

 Liver transplantation

15 (6.8)

0 (0.0)

15 (8.9)

0.026

 Neutropenia

42 (19.0)

8 (15.4)

34 (20.1)

0.447

 CCI (Median, IQR)

3 (2–5)

3 (1.25–4)

3 (2–5)

0.773

Invasive procedure/ICU

 Central venous catheter

124 (56.1)

95 (56.2)

29 (55.8)

0.955

 Artificial airway

57 (25.8)

15 (28.8)

42 (24.9)

0.565

 Intra-abdominal surgery

21 (9.5)

4 (7.7)

17 (10.1)

0.789

 Parenteral nutrition

114 (51.6)

25 (48.1)

89 (52.7)

0.563

 ICU Stay

157 (71.0)

35 (67.3)

122 (72.2)

0.497

Previous antibiotic use

 Ampicillin

29 (13.1)

5 (9.6)

24 (14.2)

0.392

 Glycopeptide

121 (54.8)

33 (63.5)

88 (52.1)

0.149

 3rd- or 4th-generation cephalosporin

84 (38.0)

16 (30.8)

68 (50.2)

0.219

 Carbapenem

123 (55.7)

27 (51.9)

96 (56.8)

0.535

 Piperacillin/tazobactam

132 (59.7)

29 (55.8)

103 (60.9)

0.506

 Metronidazole

33 (14.9)

7 (13.5)

26 (15.4)

0.734

 Fluoroquinolone

68 (30.8)

12 (23.1)

56 (33.3)

0.162

 Aminoglycoside

20 (9.0)

7 (13.5)

13 (7.7)

0.266

 Linezolid

16 (7.2)

3 (5.8)

13 (7.7)

0.768

  1. Data presented as numbers (%) unless indicated otherwise. BMI, body-mass index; LC, liver cirrhosis; AKI, acute kidney injury; RRT, renal replacement therapy, CCI, Charlson comorbidity index; IQR, interquartile range; ICU, intensive care unit